Affinity DataEC50: 63nMAssay Description:Inhibition of HIV/EBOV GP Y517S mutant infected in 293T cells assessed as reduction in virus entryMore data for this Ligand-Target Pair
Affinity DataEC50: 63nMAssay Description:Inhibition of HIV/EBOV GP T519V mutant infected in 293T cells assessed as reduction in virus entryMore data for this Ligand-Target Pair
Affinity DataEC50: 200nMAssay Description:HEp-2 cells were plated in 96-well plates at the density of 40,000 cells/well. On the next day, modified vaccinia virus Ankara-T7 (MVA-T7) at the mul...More data for this Ligand-Target Pair
Affinity DataEC50: 250nMAssay Description:HEp-2 cells were plated in 96-well plates at the density of 40,000 cells/well. On the next day, modified vaccinia virus Ankara-T7 (MVA-T7) at the mul...More data for this Ligand-Target Pair
Affinity DataEC50: 500nMAssay Description:HEp-2 cells were plated in 96-well plates at the density of 40,000 cells/well. On the next day, modified vaccinia virus Ankara-T7 (MVA-T7) at the mul...More data for this Ligand-Target Pair
Affinity DataEC50: 800nMAssay Description:HEp-2 cells were plated in 96-well plates at the density of 40,000 cells/well. On the next day, modified vaccinia virus Ankara-T7 (MVA-T7) at the mul...More data for this Ligand-Target Pair
Affinity DataEC50: 1.02E+3nMAssay Description:Inhibition of Ebola virus Sudan envelope glycoprotein-mediated cell entry in human HuH7 cells treated with 30 mins pre-treated pseudovirus/compopund ...More data for this Ligand-Target Pair
Affinity DataEC50: 2.50E+3nMAssay Description:HEp-2 cells were plated in 96-well plates at the density of 40,000 cells/well. On the next day, modified vaccinia virus Ankara-T7 (MVA-T7) at the mul...More data for this Ligand-Target Pair